Anthony T. Reder to Recombinant Proteins
This is a "connection" page, showing publications Anthony T. Reder has written about Recombinant Proteins.
Connection Strength
0.242
-
Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther. 2006 Apr; 110(1):35-56.
Score: 0.058
-
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Neurology. 2004 Jun 08; 62(11):1922-3.
Score: 0.053
-
Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases. J Interferon Cytokine Res. 2002 Mar; 22(3):311-9.
Score: 0.045
-
Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J Neuroimmunol. 1995 Aug; 61(1):27-34.
Score: 0.029
-
Astrocyte cytolysis by MHC class II-specific mouse T cell clones. Transplantation. 1993 Aug; 56(2):393-9.
Score: 0.025
-
Interferon-gamma and tumour necrosis factor induce expression of major histocompatibility complex antigen on rat retinal astrocytes. Br J Ophthalmol. 1991 Aug; 75(8):473-5.
Score: 0.022
-
T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. Cell Immunol. 1993 Jan; 146(1):96-106.
Score: 0.006
-
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. Ann Neurol. 1991 Jul; 30(1):42-7.
Score: 0.005